Neuralstem Receives Final Notice of Allowance for New Stem Cell Immortalization Technology Patent

<p>ROCKVILLE, Md., Jan. 26 /PRNewswire-FirstCall/ — Neuralstem, Inc. (NYSE Alternext US: CUR) today announced that it has received Official Notice of Allowance for its patent application, number 10/047,352, for Stable Neural Stem Cell Lines from the US Patent and Trade Office (USPTO). This patent covers the technology to immortalize any human…</p>